The Clorox Company (NYSE:CLX) shares, rose in value on Thursday, August 04, with the stock price down by -3.71% to the previous day’s close as strong demand from buyers drove the stock to $139.20.
Actively observing the price movement in the recent trading, the stock is buoying the session at $144.57, falling within a range of $141.97 and $145.25. The value of beta (5-year monthly) is 0.18 whereas the PE ratio is 39.20 over 12-month period. Referring to stock’s 52-week performance, its high was $186.86, and the low was $120.50. On the whole, CLX has fluctuated by -0.12% over the past month.
With the market capitalization of The Clorox Company currently standing at about $17.85 billion, investors are eagerly awaiting this quarter’s results, scheduled for Oct 31, 2022 – Nov 04, 2022. The company’s Forward Dividend Ratio is 4.72, with its dividend yield at 3.26%. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $1.36, which is expected to increase to $1.21 for fiscal year $5.26 and then to about $6.02 by fiscal year 2024. Data indicates that the EPS growth is expected to be 28.30% in 2024, while the next year’s EPS growth is forecast to be 14.40%.
Analysts have estimated the company’s revenue for the quarter at $1.85 billion, with a low estimate of $1.84 billion and a high estimate of $1.88 billion. Wall Street analysts also predicted that in 2024, the company’s y-o-y revenues would reach $7.33 billion, representing an increase of 3.10% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that CLX’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
18 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The stock is rated as a Hold by 6 analyst(s), 1 recommend it as a Buy and 2 called the CLX stock Overweight. In the meantime, 2 analyst(s) believe the stock as Underweight and 7 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Underweight.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CLX currently trading nearly -4.36% and -0.80% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.74, while the 7-day volatility ratio is showing 2.42% which for the 30-day chart, stands at 2.41%. Furthermore, The Clorox Company (CLX)’s beta value is 0.18, and its average true range (ATR) is 3.66. The company’s stock has been forecasted to trade at an average price of $134.73 over the course of the next 52 weeks, with a low of $114.00 and a high of $165.00. Based on these price targets, the low is 18.1% off current price, whereas the price has to move -18.53% to reach the yearly target high. Additionally, analysts’ median price of $132.00 is likely to be welcomed by investors because it represents an increase of 5.17% from the current levels.
A comparison of The Clorox Company (CLX) with its peers suggests the former has fared considerably weaker in the market. CLX showed an intraday change of -3.71% in today’s session so far, and over the past year, it shrunk by -11.88%%. In comparison, The Procter & Gamble Company (PG) has moved higher at 0.52% today and is up 0.65% over the past 12 months. Additionally, there is a loss of 0.00% for Ecolab Inc. (ECL) in recent trading while the stock has seen an overall depriciation of -23.86%% over the past year. The PE ratio stands at 39.20 for The Clorox Company, compared to 25.32 for The Procter & Gamble Company. Other than that, the overall performance of the S&P 500 during the today’s session so far shows that it lost -0.35%. Meanwhile, the Dow Jones Industrial Slipped by -0.39%.
Data on historical trading for The Clorox Company (NYSE:CLX) indicates that the trading volumes over the past 10 days have averaged 1.26 million and over the past 3 months, they’ve averaged 1.38 million. According to company’s latest data on outstanding shares, there are 123.18 million shares outstanding.
Nearly 0.10% of The Clorox Company’s shares belong to company insiders and institutional investors own 80.50% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.45 million shares as on Jul 14, 2022, resulting in a short ratio of 5.11. According to the data, the short interest in The Clorox Company (CLX) stood at 6.06% of shares outstanding as of Jul 14, 2022; the number of short shares registered in Jun 14, 2022 reached 7.43 million. The stock has fallen by -17.09% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CLX stock heading into the next quarter.